SPOTLIGHT -
OXiGENE Inc. named Eugene de Juan Jr., MD, to its clinical trial advisory board.
Prevent Blindness promoting contact lens safety
EyePod: Week in Review - September 24, 2023
Novartis finalizes divestment of ‘front of eye’ ophthalmology assets
EyePod: Transforming the MIGS pipeline into clinical reality
Outlook Therapeutics requests Type A meeting with FDA
Humonix Biosciences debuts new 3D human tissue model